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The NOD2 receptor is crucial for 
immune responses towards New 
World Leishmania species
Jéssica Cristina dos Santos1,2, Michelle S. M. A. Damen1, Marije Oosting1, Dirk J. de Jong3, Bas 
Heinhuis1, Rodrigo Saar Gomes2, Carla Santos Araújo4, Mihai G. Netea1,5, Fátima Ribeiro-Dias 
 2 & Leo A. B. Joosten1,2
American Tegumentary Leishmaniasis is a chronic infection caused by Leishmania protozoan. It is not 
known whether genetic variances in NOD-like receptor (NLR) family members influence the immune 
response towards Leishmania parasites and modulate intracellular killing. Using functional genomics, 
we investigated whether genetic variants in NOD1 or NOD2 influence the production of cytokines by 
human PBMCs exposed to Leishmania. In addition, we examined whether recognition of Leishmania 
by NOD2 contributes to intracellular killing. Polymorphisms in the NOD2 gene decreased monocyte- 
and lymphocyte-derived cytokine production after stimulation with L. amazonensis or L. braziliensis 
compared to individuals with a functional NOD2 receptor. The phagolysosome formation is important 
for Leishmania-induced cytokine production and upregulation of NOD2 mRNA expression. NOD2 is 
crucial to control intracellular infection caused by Leishmania spp. NOD2 receptor is important for 
Leishmania recognition, the control of intracellular killing, and the induction of innate and adaptive 
immune responses.
American Tegumentary Leishmaniasis (ATL) is a vector-borne parasitic disease caused by Leishmania protozoan 
that is characterized by lesions of the skin and oral or nasopharyngeal mucosa. Among the species of Leishmania 
and Viannia subgenus, L. (L.) amazonensis and L. (V.) braziliensis cause ATL leading to different clinical forms, 
which are dependent on the parasite species and the immune system of the host1. Both L. amazonensis and L. 
braziliensis can cause localized cutaneous leishmaniasis (LCL). In the most severe cases of Leishmaniasis, L. ama-
zonensis can cause diffuse cutaneous lesions (DCL) and L. braziliensis can cause mucocutaneous lesions (ML)2.
Innate immune cells such as macrophages, neutrophils, and natural killer cells recognize microorganisms 
through interaction between microbial ligands (MAMPs) with their pattern recognition receptors (PRRs). These 
PRRs include Toll-like receptors (TLRs) and NOD-like receptors (NLRs)3,4. The Leishmania membrane has 
lipophosphoglycans (LPG), glycoinositolphospholipids (GIPLs), and glycoprotein 63 (gp63) as the main mol-
ecules that are recognized by innate immune cells5,6. Recent studies have shown the involvement of TLRs in 
recognizing some of these molecules. LPG and GIPLs are recognized by TLR4 and TLR2, respectively. TLR9 also 
plays a role in recognizing the DNA of Leishmania spp. These mechanisms lead to induction of cytokines and 
microbicidal molecules after exposure to Leismania spp.7–11. In addition to, NLRs are important receptors for 
recognition of several microorganisms12. However, few studies have described their role in Leishmania recogni-
tion. Lima Junior et al13 have shown that the NLRP3 inflammasome plays an important protective role during 
L. amazonensis infection in a mouse model. Conversely, it was showed that NLRP3 activation followed by IL-1β 
production mediates the detrimental CD8+ T cell-mediated cytotoxicity in tegumentary leishmaniasis, causing 
lesions/chronic inflammation in mouse model of infections caused by L. braziliensis or L. major14. NLRP3 can 
also contribute to mouse susceptibility to L. major by increasing neutrophils recruitment, which plays a crucial 
role in the development of nonhealing lesions15. Recently, in patients with visceral leishmaniasis and in a murine 
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infection model with L. infantum, the NOD2-RIPK2 pathway has been found to be involved in the development 
of the Th1-type response16, the most important response against Leishmania spp. Because the innate immune 
response is important in driving the acquired immune response, the efficient recognition of the parasite by PRRs 
improves the host resistance16.
Leishmania recognition by monocytes or macrophages through TLRs leads to the production of proinflammatory 
cytokines such as tumor necrosis factor (TNFα), interleukin (IL)-6, and interferon gamma (IFNγ), which all con-
tribute for the exacerbated inflammation in leishmaniasis lesions11,17–19. Following NLRP3 inflammasome activation, 
IL-1β can be produced and contributes to the control of murine Leishmania infection13. Besides inflammation, these 
proinflammatory cytokines are important for controlling the Leishmania infection by inducing microbicidal mole-
cules, such as reactive oxygen and nitrogen intermediates (ROI, RNI), which are crucial for the parasite killing10,19–22.
Since it is known that the immunogenetic background of the patients is one of the most important factors to 
determine the clinical outcome of leishmaniasis23, we investigated the role of genetic variants in genes of the NLR 
family for the Leishmania-induced immune response.
Results
Individuals heterozygous for NOD2 mutation produce less cytokines after Leishmania spp. 
exposure compared to individuals with wild-type NOD2. We explored whether SNPs in NLR family 
members NOD1 and NOD2 influence the production of cytokines after stimulation with Leishmania parasites. 
Through these analyses, we found that the NOD2 receptor plays an important role in the immune response 
against Leishmania spp. (Fig. 1). The results demonstrated that individuals heterozygous for NOD2 Leu1007insC 
polymorphism displayed significantly lower production of TNFα, IL-1β, IL-6, IL-8 and IFNγ for either L. ama-
zonensis or L. braziliensis stimulation (Fig. 1A,B). Interestingly, NOD2 was only important for IL-17 induced 
by L. amazonensis, while L. braziliensis practically did not induce IL-17 production (Fig. 1B). Confirming the 
relevance of this NOD2 mutation for cytokine induction, the NOD2 agonist MDP induced lower cytokine pro-
duction when added to PBMCs from individuals with the Leu1007insC variance, compared to the control sub-
jects (Fig. 1A). Evaluation of other common polymorphisms in the NOD2 gene revealed no differences in the 
Leishmania-induced cytokine production (Figs S1 and 2). In addition to NOD2, we also investigated whether 
the NOD1 receptor could play a role in the cytokine induction after Leishmania exposure. In contrast to NOD2, 
no differences in monocyte- or lymphocyte-derived cytokine production were noted when PBMCs homozygous 
for NOD1 Glu796Lys were stimulated with L. amazonensis or L. braziliensis (Fig. 1C). Using the NOD1 agonist 
FK156, we demonstrated that Glu796Lys variance results in loss of function of NOD1 (Fig. 1C).
Phagolysosome formation is important for Leishmania-induced cytokine production and 
upregulation of NOD2 mRNA expression. In order to investigate whether Leishmania could upregu-
late the mRNA expression of NOD2, human PBMCs were incubated for 24 h with either parasite lysates or live 
promastigote forms of both L. amazonensis or L. braziliensis. The use of both forms of Leishmania stimuli was 
determined by the need to examine whether NOD2 is activated by Leishmania fragments which means that the 
parasites needs to be degraded intracellularly. Figure 2A showed that lysates as well as intact parasites of both 
Leishmania spp. were able to increase the NOD2 mRNA expression but not NOD1 mRNA. As positive controls 
FK-156 and MDP both could upregulation NOD1 or NOD2 mRNA expression respectively (Fig. 2A).
To examine whether degradation of the parasite by the phagolysosome is essential for Leishmania-induced 
cytokine production we inhibited the formation of phagolysosomes. PBMCs were incubated in the absence 
or presence of bafilomycin A1, a chemical compound that prevents maturation of parasitophorus vacuoles 
by inhibiting fusion between phagosomes and lysosomes24. Figure 2B shows a remarkable decrease in TNFα 
and IL-1β production after exposure to promastigote forms of either L.amazonensis and L. braziliensis in the 
presence of bafilomycin A1 (Fig. 2B). For IL-6, a decrease was observed after exposure to L. amazonensis and 
despite a tendency to reduction after exposure to L. braziliensis the difference did not achieve statistical signif-
icance (p = 0.0938). No differences in TNFα, IL-1β or IL-6 concentrations were observed when lysates of both 
Leishmania spp. were used to activate PBMCs in absence or presence of bafilomycin A1 (Fig. 2B).
To confirm the pivotal role of NOD2 in the recognition of Leishmania, HEK-293 cells overexpressing NOD2 
were exposed to either lysates or live promastigote forms of either L. amazonensis or L. braziliensis. We observed 
a strong increase in IL-8 production after stimulation with either lysates or promastigote forms of Leishmania 
pecies when NOD2 was present in the HEK-293 cells (Fig. 2C). A similar effect in IL-8 production was observed 
when NOD2 agonist MDP was added as a positive control. A potent TLR4 agonist (LPS) was used as negative 
control, showing no elevated IL-8 production. To validate the HEK-293-NOD2 reporter cells, we determined 
NOD2 mRNA expression before and after MDP exposure by quantitative real-time PCR (Fig. S3).
PBMCs isolated from patients bearing NOD2 (3020insC) mutation confirmed the crucial role of 
NOD2 for Leishmania-induced cytokine production. Additional experiments were performed to confirm 
the role of NOD2 in Leishmania recognition. To this end, PBMCs carrying the NOD2 frameshift (3020insC) muta-
tion were stimulated with live parasites or lysates of parasites for 24 h. The production of cytokines was compared 
with PBMCs isolated from healthy individuals (wt). As expected, cytokine concentrations were complete absent in 
individuals homozygous for the 3020insC frameshift mutation when PBMCs where stimulated with MDP (Fig. 3A). 
LPS-induced cytokine production was similar between PBMCs isolated from subjects carrying the 3020insC 
frameshift mutation and healthy controls (Fig. 3A). Production of TNFα, IL-1β, IL-6, IL-8, IFNγ was significantly 
decreased in PBMCs bearing the NOD2 3020insC frameshift mutation compared to PBMCs of individuals without 
this mutation after exposure to lysates or promastigote forms of both L. amazonensis and L. braziliensis (Fig. 3A and B). 
Of high interest, a reduction of IL-17 production was only observed after exposure to L. amazonensis (Fig. 3B).
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To investigate the downstream pathway of NOD2 signalling, we stimulated human PBMCs in the absence 
or presence of Ponatinib, a drug that potently inhibits the phosphorylation of RIPK225. RIPK2 is the impor-
tant kinase for the NOD2 signalling cascade26. A significant reduction in TNFα, IL-1β and IL-6 production was 
observed when PBMCs were incubated with lysates or promastigote forms of both L. amazonensis and L. brazil-
iensis in the presence of Ponatinib (Fig. 3C). A dose-response experiment with Ponatinib was performed and no 
cytotoxicity of Ponatinib to human cells or parasites was found (Fig. S4).
NOD2 is important to control intracellular infection caused by Leishmania spp. We investigated 
whether NOD2 plays a role in controlling Leishmania spp. infection in human primary macrophages. To this 
end, monocyte-derived macrophages from individuals homozygous for the NOD2 3020insC polymorphism were 
compared with macrophages from healthy individuals. Both types of macrophages were infected with either 
promastigote forms of L. amazonensis or L. braziliensis. Figure 4A shows an increase of the macrophage infection 
index in cells isolated from individuals carrying the NOD2 loss-of-function mutation compared with healthy con-
trols (wt). Similar results were found in primary human macrophages pre-treated with Ponatinib, which showed 
an increase in the infection index compared to vehicle-treated macrophages (Fig. 4B). The results demonstrated 
that the NOD2 receptor plays an important role in the control of Leishmania infection in human macrophages.
Figure 1. NOD2 but not NOD1 plays an important role in monocyte-and lymphocyte-derived cytokines 
induced by after Leishmania pecies stimulation. Peripheral blood mononuclear cells (PBMCs, 5 × 105 
cells/100 μL) from healthy individuals genotyped for NOD1 (Glu796Lys) and NOD2 (1007finsC) were 
stimulated with different stimuli including lysates of Leishmania spp. (50 μg/mL, L. (L.) amazonensis: L. amaz; 
L. (V.) braziliensis: L. braz), FK156 (10 μg/mL), MDP (10 μg/mL); Medium: non-stimulated cells. TNFα, 
IL-6, IL-1β and IL-8 concentrations were measured in supernatants by ELISA after 24 h of incubation. IFNγ 
and IL-17 were determined after 7 days of incubation: the NOD2 (A and B) and NOD1 (C) genotype. Bars 
represent individuals carrying no SNP (wild type, Wt, white bars), heterozygous SNP carries (He, black bars), 
or homozygous variation (Ho, grey bars). Data represent the mean ± SEM. *p < 0.05; Mann-Whitney U-test (A 
and B; Wt vs He); (C; Wt vs Ho).
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Discussion
In the present study, we investigated the role of the NLR family members NOD1 and NOD2 in the induction of 
cytokines in human PBMCs after exposure to New World Leishmania spp. Results showed that whereas NOD2 
plays an important role in parasite-induced cytokines, NOD1 is not relevant. Moreover, NOD2 is important 
for microbicidal activity of human macrophages contributing to the control of Leishmania spp. infection. This 
is the first report describing the NOD2 involvement in activation of human cells by New World Leishmania 
spp. Recently, a study in mice with L. infantum demonstrated that the activation of NOD2-RIP2 pathway drives 
the development of a Th1 instead of Th17 immune response16. These results demonstrated an important role of 
NOD2 in controlling Leishmania infection.
Figure 2. Leishmania species induce NOD2 mRNA expression and phagolysosome formation is important 
for Leishmania-induced cytokine production. (A and B) Peripheral blood mononuclear cells (PBMCs, 5 × 105 
cells/100 μL) from healthy individuals were stimulated with either lysates (50 μg/mL) or promastigotes (1 × 105 
parasites) of Leishmania species (L. (L.) amazonensis: L. amaz; L. (V.) braziliensis: L. braz); Medium (non-
stimulated cells), FK156 (10 μg/mL), MDP (10 μg/mL) and LPS (10 ng/mL) were used as controls. (B) In 
some experiments cells were incubated in the absence (white) or presence (gray) of bafilomycin A1 (250 nM). 
Medium plus Vehicle (DMSO). (A) NOD1 and NOD2 mRNA expression were determined by quantitative real-
time PCR after 24 h of incubation. (B) TNFα, IL-6 and IL-1β concentrations were determined in supernatants 
by ELISA after 24 h of incubation. Data represent the mean ± SEM, *p < 0.05; Wilcoxon test (A) (Medium vs 
stimuli) (B) (Vehicle vs Bafilomycin) (n = 6, in 2 independent experiments done in duplicates). (C) Embryonic 
kidney (HEK)-293 cells (1 × 106 cells/100 µL) transfected or not with NOD2 were stimulated for 24 h with 
lysates of Leishmania species (50 μg/mL) or promastigote forms (2 × 106 parasites) in the stationary growth 
phase of L. amaz; L. braz. Medium, LPS (10 ng/mL), and MDP (10 μg/mL) were included as controls. Protein 
levels of IL-8 were determined by ELISA in supernatants. Data represent the mean ± SEM of three independent 
experiments, *p < 0.05; Paired t-test (HEK-293 vs HEK + NOD2).
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SNPs in the NOD2 receptor are related to autoinflammatory diseases such as Crohn’s disease and Blau syndrome27–29. 
In general, as a consequence, individuals carrying these mutations have a reduced NF-κB activation after recognition 
of specific pathogen-associated NOD2 ligands, which interfere in cytokine production30. Mutations in NOD1 lead 
to a reduced capacity to detect their ligands31. To evaluate the role of genetic variance in NOD1 and NOD2 in the 
immune response to Leishmania antigens, we applied a functional genomics approach as reported recently32–34. Using 
whole exome sequencing data of 100 subjects, we selected SNPs that are frequently present in NOD1 or NOD2 with 
a predicted loss or gain of function35. Here, we showed that one particular genetic variance in NOD2 (Leu1007finsC) 
downregulates the production of monocyte-derived cytokines such as TNFα, IL-1β, IL-6, IL-8 as well as IFNγ after 
exposure to lysates of either L. amazonensis or L. braziliensis. Remarkably, IL-17 was induced after exposure to lysates 
of L. amazonensis, but not L. braziliensis in a NOD2-dependent manner. The results indicate that in addition to its role 
in activation of the innate immunity, NOD2 shapes the adaptive immune response against Leishmania spp. Our results 
are partially in agreement with the results demonstrated by Nascimento et al.16, in which, the authors showed that in a 
murine model of L. infantum infection, the development of Th1 responses and the production of IFNγ was dependent 
on NOD2. However, the authors showed that the NOD2 pathway was not relevant for Th17 development. In contrast, 
we demonstrated that in human PBMCs, IL-17 production is NOD2-dependent only after exposure to L. amazonensis. 
These results could be ascribed to the differences among Leishmania spp. as well as to differences in human and mouse 
immune responses36. Here, besides Leishmania antigens (parasite lysates) or live promastigotes increased cytokines 
in a NOD2-dependent manner they upregulated NOD2, but not NOD1 mRNA expression in PBMCs. These results 
strengthened the involvement of NOD2 but not NOD1 in Leishmania spp.-induced immune responses.
Figure 3. NOD2 plays an important role in the cytokines after Leishmania stimulation. (A,B) Peripheral blood 
mononuclear cells (PBMCs, 5 × 105 cells/100 μL) from healthy individuals (n = 8) carrying no mutation in 
NOD2 (3020insC) (Wt; white bars) and from individuals carrying a mutation in NOD2 receptor (n = 4; grey 
bars) were stimulated with either lysates (50 μg/mL) or promastigotes (1 × 105 parasites) of Leishmania species 
(L. (L.) amazonensis: L. amaz; L. (V.) braziliensis: L. braz); Medium (non-stimulated cells), MDP (10 μg/mL) 
and LPS (10 ng/mL) were used as controls. (A) TNFα, IL-6 and IL-1β concentrations were determined in 
supernatants by ELISA after 24 h incubation. (B) IFNγ and IL-17 were determined after 7 days of incubation in 
supernatants by ELISA; Data represent the mean ± SEM, *p < 0.05; Mann-Whitney U-test (Wt vs 3020insC). 
(C) Peripheral blood mononuclear cells (PBMCs, 5 × 105 cells/100 μL) from healthy individuals were stimulated 
with either lysates (50 μg/mL) or promastigotes (1 × 105 parasites) of Leishmania species (L. (L.) amazonensis: L. 
amaz; L. (V.) braziliensis: L. braz) in the presence (grey bars) or absence (white bars) of the Ponatinib (100 nM); 
Medium (non-stimulated cells) plus Vehicle (DMSO) and MDP (10 μg/mL) were used as controls. TNFα, IL-6 
and IL-1β concentrations were determined by ELISA, after 24 h incubation. Data represent the mean ± SEM, 
*p < 0.05; (DMSO vs Ponatinib; n = 6, in 2 independent experiments done in duplicates, by Wilcoxon test).
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To confirm that NOD2 is relevant for Leishmania-induced cytokine production, we overexpressed NOD2 in 
HEK-293 cells and showed that these NOD2-transfected cells produced significantly higher IL-8 concentrations 
after exposure to parasite lysates or promastigote forms of either L. amazonensis or L. braziliensis, compared to 
control HEK-293 cells. Although, NOD2 is known as a receptor that recognizes structures present in the bacteria 
cell wall37,38, the results presented here suggest that the NOD2 receptor also recognizes protozoan structures.
It is well described that PBMCs from patients with Crohn’s disease carrying the NOD2 (NOD2 3020insC) 
mutation display a reduction in cytokine production after exposure to several microbial ligands or pathogens39,40. 
In our study, we also used PBMCs from subjects carrying NOD2 3020insC mutation and demonstrated a signif-
icant decrease in the production of proinflammatory cytokines after Leishmania spp. exposure. These data are 
in line with the results of the NOD2 genetic variance Leu1007finsC and the HEK-NOD2 cells, underlining the 
pivotal role of NOD2 in the recognition of Leishmania spp.
An additional line of evidence that the NOD2 pathway is important for Leishmania-induced immune 
responses, are our results with the RIPK2 inhibitor (Ponatinib). The inhibition of RIPK2 led to almost complete 
abolishment of Leishmania cytokine production. These data demonstrate previously unknown role for human 
NOD2 in the recognition of L. amazonensis or L. braziliensis and make it tempting to speculate that individuals 
carrying NOD2 polymorphisms might be more susceptible to ATL.
The ligand of Leishmania parasites that binds to NOD2 remains unknown but we showed that degradation 
of Leishmania is a prerequisite for cytokine production. Bafilomycin A1, a specific inhibitor of the phagosome 
acidification and blocker of phagosome maturation impaired the proinflammatory cytokine production only 
after exposure to live promastigote forms of L. amazonensis or L. braziliensis, whereas no effect was observed 
after exposure to lysates of both these species. Enzymes present in the phagolysosomes, such as lysozyme, may 
degrade Leishmania to release NOD2 ligands in a similar process that happens with Listeria monocytogenes41. 
Future studies are warranted to investigate which microbial components of Leishmania are recognized by NOD2.
It is known that the production of proinflammatory cytokines can play a double role in infection caused by 
Leishmania spp., contributing to the control of the infection but also favoring inflammation and tissue destruc-
tion42,43. Here we demonstrated that loss of NOD2 signalling impairs intracellular Leishmania killing. The exact 
mechanisms involved in NOD2-mediated Leishmania killing need to be further explored, although it is known 
that proinflammatory cytokines promote the induction of microbicidal molecules after infection with Leishmania 
spp.10,19–22,44. Moreover, it is known that NOD2 plays an important role in induction of microbicidal mechanisms 
including autophagy, antimicrobial peptides and ROS production, which are essential to control infections caused 
by intracellular pathogens45–47.
To conclude, our study showed for the first time that the human NOD2 pathway is important for Leishmania 
recognition, the induction of innate and adaptive immune responses, and the control of intracellular killing of 
the parasite (Fig. 5). Our findings provide the first evidence that genetic variances in NOD2 are associated with 
differences in the human immune response towards Leishmania spp. The relevance of the NOD2 pathway in the 
susceptibility to or severity of human ATL needs to be investigated in the near future.
Figure 4. NOD2 plays a role in control of Leishmania spp. infection. Monocyte-derived macrophages were 
obtained from PBMCs from wild type (wt) individuals (n = 4) carrying no mutations in NOD2 receptor 
(3020insC) (black circles) and individuals carrying mutations in NOD2 (n = 2, black squares) (A), after 5 days 
of differentiation. On day 5, macrophages (5 × 105 cells) were infected with promastigote forms of either L. 
(V.) braziliensis and L. (L.) amazonensis (2.5 × 105 parasites) during 4 h. (B) Macrophages from wt individuals 
(n = 4) were incubated in the absence (black balls - Vehicle DMSO) or presence (black squares) of Ponatinib 
(100 nM) 1 h before. Cells were washed out to remove the non-internalized parasites after 4 h, Ponatinib was 
added again and cells were incubated for 48 h. Coverslips were collected to determine macrophage infection 
index. Data represent individual values and horizontal lines represent medians. *p < 0.05; Wilcoxon test 
(DMSO vs Ponatinib).
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Methods
Ethics Statement. The study was approved by Ethics Committee of Radboud University Nijmegen, the 
Netherlands (no. 42561.091.12). Experiments were conducted according to the principles expressed in the 
Declaration of Helsinki. All individuals gave written informed consent to donate blood.
200FG cohort. Healthy individuals with a Dutch European genetic background that were recruited as part of 
the 200FG study34 participated in the study. The volunteers were between 23–73 years old, and consisted of 77% 
men and 23% women.
Isolation of genomic DNA and single-nucleotide polymorphism (SNP) analysis. DNA was iso-
lated from whole blood by using the isolation Gentra Pure Gene Blood kit (Qiagen), according to the manufac-
turer’s protocol. SNPs in the analyzed receptor genes were selected from the National Center for Biotechnology 
Information SNP database (http://www.ncbi.nlm.nih.gov/snp/) upon previously described associations with 
human diseases and a minor allele frequency of at least 5% among different populations. In total, 7 SNPs in NOD1 
and NOD2 receptors were selected and genotyped (Supplementary Table 1). Gene fragments were amplified by 
commercially available TaqMan® SNP Genotyping Assays according to the manufacturer’s protocol on the AB 
StepOnePlus polymerase chain reaction system (Applied Biosystems). Quality control was performed by the 
incorporation of positive and negative controls and duplication of random samples across different plates.
Leishmania cultures and lysates. L. amazonensis (IFLA/BR/67/PH8) reference strain and MHOM/
BR/2003/IMG L. braziliensis, a clinical isolate obtained from a LCL patient (Leishbank IPTSP/UFG)48, were used. 
Promastigote forms were cultured in Grace’s Insect Medium, (Gibco - Life Technologies) and prepared for exper-
iments as described by dos Santos et al.19. To obtain lysates of Leishmania, promastigotes (1 × 109 cells/mL) were 
lysed by 5 freeze-thaw cycles in liquid nitrogen and water bath at 37 °C followed by protein quantification using 
the Pierce BCA protein assay (Thermo Scientific). For cell stimulations, parasites were suspended in RPMI 1640 
medium (Sigma) and added to the cultures as described below.
Human embryonic kidney cell line (HEK) stimulation. Transfection of HEK-293 cells with human 
NOD2 was performed as previously described by Laayouni et al.49 and culture conditions are described as sup-
plementary material. Non-transfected or NOD2-transfected HEK-293 cells (1 × 106 cells) were added to 96-well 
flat-bottom plates (Greiner) in the presence of either E. coli lipopolysaccharide (LPS, O111:B4, 10 ng/mL; Sigma), 
further purified based on50, muramyl dipeptide (MDP, 10 μg/mL; Sigma), lysates or promastigotes (2 × 106 par-
asites) of L. braziliensis or L. amazonensis in a final volume of 200 μL. After 24 h of incubation, at 37 °C and 5% 
CO2, supernatants were collected and stored at −20 °C until analysis of IL-8 production.
Figure 5. Schematic overview of the role of NOD2 receptor in Leishmania spp. recognition and control. 
(A) General overview of NOD2 pathway: The NOD2 receptor is engaged by its respective ligand, driving 
the activation of RIPK2, which is followed by NF-κB activation and translocation to the nucleus leading to 
inflammatory gene transcription. In addition, microbicidal molecules can be produced. NOD2 genetic variances 
can lead to a non-functional NOD2 receptor, as a consequence, the cytokine and microbicidal molecule 
production mediated by NOD2 can be affected. (B) Phagolysosome-mediated degradation of Leishmania spp. 
promastigote forms leads to parasite antigen release in the cytoplasm of infected cells. This may drive the NOD2 
activation and subsequently induction of NF-κB gene transcription and microbicidal molecule production. L. 
(L.) amazonensis and L.(V.) braziliensis-NOD2-mediated proinflammatory cytokines produced by innate and 
adaptive cells might contribute for controlling of the infection.
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Isolation of human peripheral blood mononuclear cells (PBMC) and treatments. Venous blood 
was obtained from eight healthy individuals bearing the wild-type allele of NOD2 (wild type, wt) and from four 
homozygous individuals for the NOD2 3020insC mutation presenting Crohn’s disease. Isolation of PBMCs was 
performed as described previously39, by density gradient centrifugation of blood diluted 1:1 in pyrogen-free 
saline overlayed on Ficoll-Paque (Pharmacia Biotech). PBMCs were suspended in RPMI 1640 medium with 
50 mg/mL gentamicin, 2 mmol/L L-glutamine, and 1 mmol/L pyruvate (Invitrogen). The number was adjusted 
to 5 × 106 cells/mL. Cells (5 × 105 cells/mL) were added to round-bottom 96-well plates (Greiner) and incubated 
with either culture medium (negative control), MDP (10 μg/ml), FK-156 (10 μg/mL, Sigma), ultra-pure E. coli 
LPS as described by Battisti & Minnick50 (O111:B4 serotype, 10 ng/mL; Sigma) or 50 μg/mL of both Leishmania 
pp. lysates or promastigotes (1 × 105 parasites) of L. braziliensis and L. amazonensis in the presence or absence 
of 10% of human pool serum. In some experiments, PBMCs were pre-incubated for 1 h with a RICK inhibi-
tor (Ponatinib, 100 nM/mL; Selleckchem) and a phagolysosome inhibitor (Bafilomycin A1, 250 nM; Invivogen) 
before cells were stimulated with lysates or promastigotes. After 24 h or 7 days, the supernatants were collected 
and stored at −20 °C until further analysis. The cell monolayers were collected by adding 200 µL of TRIzol and 
stored at −80 °C until being used for mRNA extraction.
Measurement of cytokines. Human TNFα, IL-1β, IL-6, IL-8, IL-17A and IFNγ were determined in cul-
ture supernatants using commercial Enzyme-Linked Immunosorbent Assay (ELISA) kits (Sanquin, Amsterdam, 
and R&D Systems, Minneapolis), according to the manufacturer’s protocols.
Evaluation of mRNA expression by quantitative real-time PCR (qPCR). RNA isolation was carried 
out based on the method reported by Chomzynski & Sacchi51 and the qPCR method is shortly described in sup-
plementary material. Primer sequences (Supplementary Table 2) for NOD1 and NOD2 receptors were obtained 
from the Harvard Primerbank database. Primers were purchased from Biolegio. Relative expression of mRNA 
levels was calculated and normalized for the housekeeping gene GAPDH.
Evaluation of Macrophage infection. Monocyte-derived macrophages from healthy volunteers and from 
homozygous individuals for the NOD2 3020insC mutation were obtained from PBMCs (5 × 105 cells/well) dur-
ing 5 days at 37 °C, 5% CO2. PBMCs were counted and plated into 24-well plates (Costar) over coverslips in the 
presence of RPMI-1640 medium supplemented as described above and added with 10% of human pool serum. 
Medium was refreshed every 48 h. On day 5, macrophages were infected with promastigote forms of either L. 
braziliensis or L. amazonensis (2.5 × 105 parasites) during 4 h. Cells were washed to remove non-internalized par-
asites and incubated for 48 h. Additionally, is some experiments monocyte-derived macrophages were pre-treated 
or not with Ponatinib (100 nM/mL; Selleckchem) 1 h before infection and the drug was replaced after washings. 
Coverslips were collected to determine the macrophage infection index after cells were fixed and stained with 
Giemsa (Merck Millipore), according to52 and briefly described in supplementary material.
Statistical Analysis. Data are expressed as median, interquartile, minimal and maximal values, unless oth-
erwise indicated. Differences between experimental groups were tested by Mann-Whitney U test or unpaired t 
test according to the data, or by Wilcoxon paired test, using Prism software (version 6.0; GraphPad; San Diego, 
CA, USA). Differences with p < 0. 05 were considered significant.
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